Alnylam HR chief reports initial share holdings
Alnylam Pharmaceuticals executive Melissa McLaughlin, Chief Human Resources Officer, reported her equity holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Alnylam Pharmaceuticals executive Melissa McLaughlin, Chief Human Resources Officer, reported her equity holdings in the company. She directly holds 13,353 shares of common stock, including restricted stock units that will convert into shares over time.
She also holds a stock option covering 3,567 shares of common stock at an exercise price of $325.07 per share, expiring on March 2, 2036. The option and RSUs vest over multi‑year schedules tied to her continued service.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
McLaughlin Melissa
Role
Chief Human Resources Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,567 contracts (Direct);
Common Stock — 13,353 shares (Direct)
Footnotes (2)
- F1. Includes 11,730 shares represented by restricted stock units (RSUs) granted on April 1, 2025 and 1,623 shares represented by RSUs granted on March 2, 2026, under the Second Amended and Restated 2018 Stock Incentive Plan. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of common stock.
- F2. The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
Key Figures
Common shares held: 13,353 shares
Option underlying shares: 3,567 shares
Option exercise price: $325.07/share
+4 more
7 metrics
Common shares held
13,353 shares
Directly held common stock following reported holdings
Option underlying shares
3,567 shares
Common stock underlying reported stock option holding
Option exercise price
$325.07/share
Exercise price for stock option expiring March 2, 2036
RSUs from April 1, 2025 grant
11,730 shares
RSUs granted April 1, 2025 vesting over three years
RSUs from March 2, 2026 grant
1,623 shares
RSUs granted March 2, 2026 vesting over three years
Option vesting first tranche
25% of shares
Vests on first anniversary of grant date
Option full vesting period
4 years
Remaining shares vest quarterly after first anniversary
Key Terms
restricted stock units (RSUs), Second Amended and Restated 2018 Stock Incentive Plan, Stock Option (Right to Buy), vest over a three-year period, +1 more
5 terms
restricted stock units (RSUs) financial
"Includes 11,730 shares represented by restricted stock units (RSUs) granted on April 1, 2025 and 1,623 shares represented by RSUs granted on March 2, 2026"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Second Amended and Restated 2018 Stock Incentive Plan financial
"under the Second Amended and Restated 2018 Stock Incentive Plan"
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
vest over a three-year period financial
"The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries"
continuous service financial
"subject to the Reporting Persons continuous service with the Issuer as of each such vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ALNY Form 3 filing show for Melissa McLaughlin?
The filing shows that Chief Human Resources Officer Melissa McLaughlin holds 13,353 Alnylam common shares and a stock option for 3,567 shares. These positions reflect her equity-based compensation, with vesting tied to continued employment over several years.
What stock options are reported for Melissa McLaughlin in ALNY’s Form 3?
She holds a stock option to buy 3,567 Alnylam common shares at an exercise price of $325.07 per share. The option expires on March 2, 2036 and vests over four years, starting with 25% on the first anniversary of the grant date.
How are Melissa McLaughlin’s Alnylam RSUs structured?
The filing notes 11,730 RSUs granted April 1, 2025 and 1,623 RSUs granted March 2, 2026. Each grant vests in three equal annual installments over three years, contingent on her continuous service, with each RSU delivering one share of common stock at vesting.
What compensation plan covers Melissa McLaughlin’s Alnylam RSUs?
Her RSUs were granted under Alnylam’s Second Amended and Restated 2018 Stock Incentive Plan. This plan provides equity-based awards, including RSUs that vest over time, aligning executive compensation with long-term company performance and continued employment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates